Fanwood, NJ, United States of America

Chou Juitsai Liu

This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chou Juitsai Liu. Retrieved from https://idiyas.com/inventor/chou-juitsai-liu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 16.0

ph-index = 1

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Chou Juitsai Liu

Introduction

Chou Juitsai Liu is a notable inventor based in Fanwood, NJ, who has made significant contributions to the field of medicinal chemistry. His work primarily focuses on developing innovative compounds that can address various health issues.

Latest Patents

Chou Juitsai Liu holds a patent for "Carbocyclic potassium channel inhibitors." This invention relates to a class of carbocyclic compounds that are useful as potassium channel inhibitors. These compounds have potential applications in treating autoimmune disorders, cardiac arrhythmias, and similar conditions.

Career Highlights

Chou Juitsai Liu is currently employed at Merck & Company, Inc., a leading global healthcare company. His role involves research and development in the pharmaceutical sector, where he applies his expertise to create effective therapeutic solutions.

Collaborations

Chou has collaborated with esteemed colleagues, including Robert K Baker and Jianming Bao, to advance his research and innovations in the field.

Conclusion

Chou Juitsai Liu's contributions to medicinal chemistry, particularly through his patent on carbocyclic potassium channel inhibitors, highlight his role as an influential inventor in the healthcare industry. His work continues to pave the way for new treatments and advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…